FDG PET/CT and thyroid biopsy leads to neurosarcoidosis diagnosis

• Published in: Radiology Case Reports
• Main Authors: Catherine Bullock, MD, Matthew McCann, MD, Akash Sharma, MD, MBA, Jason R. Young, MD, Allie M. Metcalfe, MD, Ephraim E. Parent, MD, PhD
• Format: Article
• Language: English
• Published: Elsevier 2023-11-01
• Subjects: Neurosarcoidosis; FDG-PET; Systemic sarcoid
• Online Access: http://www.sciencedirect.com/science/article/pii/S193004332300523X
• ISSN: 1930-0433

We present a unique case of neurosarcoidosis diagnosed based on thyroid biopsy and FDG PET (Fluorodeoxyglucose positron emission tomography) imaging. A patient presented for a second opinion after being placed in hospice for rapidly progressing dementia, presumed to be due to Creutzfeldt Jakob disease despite negative workup and was unable to perform activities of daily life or communicate with his wife. The patient underwent a workup including whole-body FDG PET, which showed hypermetabolic lymph nodes as well as a hypermetabolic nodule in the thyroid. Biopsy of the lymph nodes was nondiagnostic, but the thyroid biopsy tissue yielded a diagnosis of sarcoid. After ruling out other causes and reviewing the tissue pathology, the patient was diagnosed with systemic sarcoidosis with neurological involvement and started on infliximab with rapid improvement.